Using AI to Improve Rehabilitation for Patients with Severe Mental Disorders
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
This study is testing if using AI and fun games can help people with severe mental disorders improve their social skills and get back into the community.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 82 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT06904079 on ClinicalTrials.gov |
What this trial studies
This study integrates multimodal technology, reinforcement learning, and agent-based modeling to enhance the rehabilitation of patients with severe mental disorders. It involves three phases: first, assessing user needs through community mental health facilities; second, designing and implementing gamified interventions followed by a randomized controlled trial; and third, optimizing these interventions based on user feedback and data analysis. The goal is to improve social functions and facilitate reintegration into society for these patients.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 65 diagnosed with severe mental disorders such as schizophrenia or bipolar disorder, who are registered in the Shanghai Mental Health Information Management System.
Not a fit: Patients with severe physical illnesses or organic brain diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and social integration for patients with severe mental disorders.
How similar studies have performed: While the integration of AI and gamification in mental health rehabilitation is a novel approach, similar studies have shown promise in enhancing patient engagement and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria:
* Registered in the Shanghai Mental Health Information Management System,
* Diagnosed patients with one of the six severe mental disorders: schizophrenia, schizoaffective disorder, paranoid psychosis, bipolar (affective) disorder, mental disorder due to epilepsy, and mental retardation accompanied by mental disorder,
* Aged between 18 and 65 years old, ④ Normal vision or hearing, or within the normal range after correction, ⑤ Patients or their families have provided informed consent for this study and signed the informed consent form.
Exclusion criteria:
Patients with severe physical illnesses or organic brain diseases.
Where this trial is running
Shanghai
- Shanghai Mental Health Center — Shanghai, China (Recruiting)
Study contacts
- Principal investigator: Jun Cai — Shanghai Mental Health Center
- Study coordinator: Weibo Zhang
- Email: zhangweibo600@163.com
- Phone: 86-13764694223
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.